{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:19:47Z","timestamp":1773296387440,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["heartlungcirc.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.hlc.2016.08.005","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T03:23:03Z","timestamp":1473996183000},"page":"425-432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy and Safety of Statins for Pulmonary Hypertension: A Meta-Analysis of Randomised Controlled Trials"],"prefix":"10.1016","volume":"26","author":[{"given":"Yitao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijie","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhichong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaojie","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maode","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanglin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2016.08.005_bib0240","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"Galie","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hlc.2016.08.005_bib0245","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2016.08.005_bib0250","doi-asserted-by":"crossref","first-page":"D60","DOI":"10.1016\/j.jacc.2013.10.031","article-title":"Updated treatment algorithm of pulmonary arterial hypertension","volume":"62","author":"Galie","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2016.08.005_bib0255","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/HYPERTENSIONAHA.110.157032","article-title":"Nanoparticle-mediated delivery of pitavastatin into lungs ameliorates the development and induces regression of monocrotaline-induced pulmonary artery hypertension","volume":"57","author":"Chen","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.hlc.2016.08.005_bib0260","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1164\/rccm.201003-0399OC","article-title":"Statin reverses smoke-induced pulmonary hypertension and prevents emphysema but not airway remodeling","volume":"183","author":"Wright","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2016.08.005_bib0265","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/cvr\/cvn244","article-title":"Statin ameliorates hypoxia-induced pulmonary hypertension associated with down-regulated stromal cell-derived factor-1","volume":"81","author":"Satoh","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hlc.2016.08.005_bib0270","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1465-9921-12-137","article-title":"Pleiotropic effects of statins in distal human pulmonary artery smooth muscle cells","volume":"12","author":"Ali","year":"2011","journal-title":"Respir Res"},{"key":"10.1016\/j.hlc.2016.08.005_bib0275","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrcardio.2010.136","article-title":"The role of Rho protein signaling in hypertension","volume":"7","author":"Loirand","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hlc.2016.08.005_bib0280","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.ajpath.2012.02.016","article-title":"Protein kinase G-I deficiency induces pulmonary hypertension through Rho A\/Rho kinase activation","volume":"180","author":"Zhao","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.hlc.2016.08.005_bib0285","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.pharmthera.2012.12.003","article-title":"Role of Rho-kinase and its inhibitors in pulmonary hypertension","volume":"137","author":"Duong-Quy","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.hlc.2016.08.005_bib0290","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1165\/rcmb.2014-0201OC","article-title":"Rho kinase mediates right ventricular systolic dysfunction in rats with chronic neonatal pulmonary hypertension","volume":"52","author":"Gosal","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.hlc.2016.08.005_bib0295","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1590\/S0100-879X2008000800003","article-title":"Rosuvastatin and vascular dysfunction markers in pulmonary arterial hypertension: a placebo-controlled study","volume":"41","author":"Barreto","year":"2008","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.hlc.2016.08.005_bib0300","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1161\/CIRCULATIONAHA.110.015693","article-title":"Randomized clinical trial of aspirin and simvastatin for pulmonary arterial hypertension: ASA-STAT","volume":"123","author":"Kawut","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2016.08.005_bib0305","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1042\/CS20080241","article-title":"Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension","volume":"116","author":"Lee","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.hlc.2016.08.005_bib0310","first-page":"230","article-title":"[Clinical study on simvastatin treatment of pulmonary hypertension in patients with coal worker's pneumoconiosis]","volume":"29","author":"Li","year":"2011","journal-title":"Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi"},{"key":"10.1016\/j.hlc.2016.08.005_bib0315","doi-asserted-by":"crossref","first-page":"649","DOI":"10.5812\/ircmj.8267","article-title":"Evaluation of the effects of atorvastatin on the treatment of secondary pulmonary hypertension due to chronic obstructive pulmonary diseases: a randomized controlled trial","volume":"15","author":"Moosavi","year":"2013","journal-title":"Iran Red Crescent Med J"},{"issue":"Suppl 6","key":"10.1016\/j.hlc.2016.08.005_bib0320","first-page":"12","article-title":"Evaluation of the simvastatin effects in the treatment of pulmonary hypertension (PH)","volume":"131","author":"Shahmiri","year":"2009","journal-title":"Lijec Vjesn"},{"key":"10.1016\/j.hlc.2016.08.005_bib0325","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1164\/rccm.2009111-699OC","article-title":"Simvastatin as a treatment for pulmonary hypertension trial","volume":"181","author":"Wilkins","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2016.08.005_bib0330","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1183\/09031936.00149011","article-title":"Atorvastatin in pulmonary arterial hypertension (APATH) study","volume":"40","author":"Zeng","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hlc.2016.08.005_bib0335","first-page":"352","article-title":"Effect of atorvastatin,sildenafil and their combination on pulmonary arterial hypertension","volume":"27","author":"Zheng","year":"2011","journal-title":"Journal of Clinical Cardiology"},{"key":"10.1016\/j.hlc.2016.08.005_bib0340","first-page":"1240","article-title":"Effects of bosentan combined with simvastatin on medium and severe pulmonary arterial hypertension","volume":"42","author":"Zhuang","year":"2013","journal-title":"Chongqing Medicine"},{"key":"10.1016\/j.hlc.2016.08.005_bib0345","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.hlc.2016.08.005_bib0350","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.hlc.2016.08.005_bib0355","first-page":"783","article-title":"Clinical effect of the Sofren combined with atorvastatin on chronic obstructive pulmonary disease combined pulmonary hypertension","volume":"31","author":"Zhu","year":"2015","journal-title":"Chinese Journal of Clinical Pharmacology"},{"key":"10.1016\/j.hlc.2016.08.005_bib0360","first-page":"657","article-title":"Effect of simvastatin on pulmonary hypertension in chronic pulmonary heart disease","volume":"29","author":"Guo-liang","year":"2009","journal-title":"Chinese Journal of Hospital Pharmacy"},{"key":"10.1016\/j.hlc.2016.08.005_bib0365","first-page":"288","article-title":"N-terminal pro-brain natriuretic peptide in the evaluation of sildenafil and simvastatin combination treatment in female patients with pulmonary hypertension","volume":"28","author":"Zhuang","year":"2012","journal-title":"Journal of Clinical Cardiology"},{"key":"10.1016\/j.hlc.2016.08.005_bib0370","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.healun.2010.09.011","article-title":"Effects of simvastatin on pulmonary C-fiber sensitivity in rats with monocrotaline-induced pulmonary hypertension","volume":"30","author":"Hsu","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.hlc.2016.08.005_bib0375","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/FJC.0b013e3181f4838b","article-title":"Effects of atorvastatin and L-arginine treatments on electrical field stimulation-mediated relaxations in pulmonary arterial rings of monocrotaline-induced pulmonary hypertensive rats","volume":"56","author":"Ozturk","year":"2010","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.hlc.2016.08.005_bib0380","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00210-006-0112-z","article-title":"The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin","volume":"374","author":"Rakotoniaina","year":"2006","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.hlc.2016.08.005_bib0385","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/01.CIR.0000087592.47401.37","article-title":"Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells","volume":"108","author":"Nishimura","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2016.08.005_bib0390","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3109\/10641963.2010.503295","article-title":"Effects of atorvastatin and losartan on monocrotaline-induced pulmonary artery remodeling in rats","volume":"32","author":"Xie","year":"2010","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.hlc.2016.08.005_bib0395","first-page":"541","article-title":"The effects of atorvastatin on pulmonary arterial hypertension and expression of p38, p27, and Jab1 in rats","volume":"26","author":"Gao","year":"2010","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.hlc.2016.08.005_bib0400","doi-asserted-by":"crossref","first-page":"L630","DOI":"10.1152\/ajplung.00110.2006","article-title":"Serotonin transporter protein in pulmonary hypertensive rats treated with atorvastatin","volume":"293","author":"Laudi","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.hlc.2016.08.005_bib0405","doi-asserted-by":"crossref","first-page":"L668","DOI":"10.1152\/ajplung.00491.2005","article-title":"Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension","volume":"291","author":"Taraseviciene-Stewart","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.hlc.2016.08.005_bib0410","doi-asserted-by":"crossref","first-page":"L1105","DOI":"10.1152\/ajplung.00411.2006","article-title":"Regression of chronic hypoxic pulmonary hypertension by simvastatin","volume":"292","author":"Girgis","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.hlc.2016.08.005_bib0415","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/HCO.0b013e32834659bf","article-title":"Pulmonary arterial hypertension and statins: an update","volume":"26","author":"Katsiki","year":"2011","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.hlc.2016.08.005_bib0420","first-page":"1446","article-title":"Simvastatin treatment of pulmonary hypertension: an observational case series","volume":"127","author":"Kao","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2016.08.005_bib0425","doi-asserted-by":"crossref","first-page":"D100","DOI":"10.1016\/j.jacc.2013.10.033","article-title":"Pulmonary hypertension due to left heart diseases","volume":"62","author":"Vachiery","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2016.08.005_bib0430","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0140-6736(04)16723-8","article-title":"Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Anand","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.hlc.2016.08.005_bib0435","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cardfail.2004.05.006","article-title":"Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study","volume":"11","author":"Packer","year":"2005","journal-title":"Journal of Cardiac Failure"},{"key":"10.1016\/j.hlc.2016.08.005_bib0440","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/01.CIR.0000038497.80095.E1","article-title":"Hemodynamic and neurohumoral effects of selective Endothelin A (ETA) receptor blockade in chronic heart failure: the Heart Failure ETA Receptor Blockade Trial (HEAT)","volume":"106","author":"Luscher","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2016.08.005_bib0445","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/384353a0","article-title":"Inhibition of myocardial endothelin pathway improves long-term survival in heart failure","volume":"384","author":"Sakai","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.hlc.2016.08.005_bib0450","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0735-1097(00)00649-5","article-title":"Acute hemodynamic and neurohumoral effects of selective ET(A) receptor blockade in patients with congestive heart failure. ET 003 Investigators","volume":"35","author":"Spieker","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2016.08.005_bib0455","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0140-6736(95)91504-4","article-title":"Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure","volume":"346","author":"Kiowski","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.hlc.2016.08.005_bib0460","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/01.CIR.98.21.2262","article-title":"Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure","volume":"98","author":"Sutsch","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2016.08.005_bib0465","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(08)60919-8","article-title":"Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial","volume":"371","author":"Galie","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.hlc.2016.08.005_bib0470","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/j.jacc.2009.04.007","article-title":"End points and clinical trial design in pulmonary arterial hypertension","volume":"54","author":"McLaughlin","year":"2009","journal-title":"J Am Coll Cardiol"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950616315852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950616315852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T11:31:17Z","timestamp":1536406277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950616315852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1443950616315852"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2016.08.005","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Statins for Pulmonary Hypertension: A Meta-Analysis of Randomised Controlled Trials","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2016.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}